搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
oncnursingnews
5 天
Lung Cancer Survival Improves, But Gaps in Biomarker Testing Remain
According to the American Lung Association, biomarker testing gaps and low screening rates continue to hinder lung cancer ...
HealthDay on MSN
5 天
American Lung Association Releases Annual 'State of Lung Cancer' Report
The lung cancer survival rate improved 26 percent in the last five years, according to the "State of Lung Cancer" report ...
Cure Today
5 天
Tiragolumab Plus Tecentriq Misses Survival Endpoint for Lung Cancer Subset
The primary endpoint of overall survival was missed in the SKYSCRAPER-01 study assessing tiragolumab plus Tecentriq in some ...
8 天
Lung cancer is the leading cause of cancer deaths here in Florida. Here’s why.
The Tampa Bay Times e-Newspaper is a digital replica of the printed paper seven days a week that is available to read on ...
Cancer Therapy Advisor
5 天
Top Lung Cancer Research of 2024
This page includes links to articles highlighting the top lung cancer research published on Cancer Therapy Advisor in 2024.
3 天
on MSN
Report: RI ranks high for lung cancer screening, treatment
Rhode Island ranked second for its lung cancer survival rate, with more than 35% living five years post diagnosis. The state ...
TheCourierExpress.com
1 天
Should you get screened for lung cancer?
Lung cancer is the third most common cancer and the leading cause of cancer-related deaths in the U.S., and according to the ...
FierceBiotech
2 天
AstraZeneca, Daiichi share data behind Dato-DXd do-over amid 2nd bid for lung cancer approval
AstraZeneca and Daiichi Sankyo have shared the data they believe can secure approval for datopotamab deruxtecan (Dato-DXd) at ...
3 天
on MSN
SF doctor starting initiative aimed at early detection of lung cancer in women
Dr. Heba Ismail at Sutter Health’s California Pacific Medical Center has dedicated her career to the early detection and ...
2 天
After Lung Cancer Approval, AstraZeneca's Imfinzi Goes Under FDA Priority Review For ...
AstraZeneca's Imfinzi gains FDA Priority Review for bladder cancer. Key trial data shows improved survival and progression ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈